J 2015

Flow cytometry in immunoglobulin light chain amyloidosis: Short review

FILIPOVA, Jana, Lucie ŘÍHOVÁ, Pavla VŠIANSKÁ, Zuzana KUFOVA, Elena KRYUKOVA et. al.

Basic information

Original name

Flow cytometry in immunoglobulin light chain amyloidosis: Short review

Authors

FILIPOVA, Jana (203 Czech Republic), Lucie ŘÍHOVÁ (203 Czech Republic, guarantor, belonging to the institution), Pavla VŠIANSKÁ (203 Czech Republic, belonging to the institution), Zuzana KUFOVA (203 Czech Republic), Elena KRYUKOVA (203 Czech Republic), Fedor KRYUKOV (203 Czech Republic) and Roman HAJEK (203 Czech Republic)

Edition

Leukemia Research, Oxford, Pergamon-Elsevier Science LTD, 2015, 0145-2126

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.606

RIV identification code

RIV/00216224:14110/15:00081728

Organization unit

Faculty of Medicine

UT WoS

000365335100002

Keywords in English

Flow cytometry; AL amyloidosis; Monoclonal gammopathy; Plasma cell

Tags

Tags

International impact, Reviewed
Změněno: 28/4/2016 10:59, Ing. Mgr. Věra Pospíšilíková

Abstract

V originále

Flow cytometry (FCM) has found its application in clinical diagnosis and evaluation of monoclonal gammopathies (MG). Although, research has been mainly focused on multiple myeloma (MM), nowadays FCM becomes to be potential tool in the field of AL amyloidosis. Clonal plasma cells identification and specific phenotype profile detection is important for diagnosis, monitoring and prognosis of AL amyloidosis. Therefore, FCM could be a perspective method for study not only MM but also AL amyloidosis. This review provides an overview and possibilities of FCM application in AL amyloidosis. (C) 2015 Elsevier Ltd. All rights reserved.

Links

GAP304/10/1395, research and development project
Name: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií
Investor: Czech Science Foundation